ShareHope Medicine Co Ltd (8403) — Cash Flow Reinvestment Rate
ShareHope Medicine Co Ltd (8403) has a Cash Flow Reinvestment Rate of 0.66x as of December 2025, reinvesting NT$75.10 Million (capex NT$39.14 Million plus investments NT$-35.96 Million) from operating cash flow of NT$113.37 Million. Check 8403 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ShareHope Medicine Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for ShareHope Medicine Co Ltd across 9 annual periods. Explore ShareHope Medicine Co Ltd (8403) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for ShareHope Medicine Co Ltd. For live market cap and broader valuation context, see 8403 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | NT$244.81 Million | NT$364.12 Million | NT$131.81 Million | ▲ +48.8% |
| 2024 | 0.45x | NT$120.48 Million | NT$266.68 Million | NT$93.02 Million | ▼ -77.0% |
| 2023 | 1.96x | NT$504.81 Million | NT$257.13 Million | NT$277.20 Million | ▼ -52.5% |
| 2022 | 4.14x | NT$2.66 Billion | NT$642.47 Million | NT$1.28 Billion | ▲ +833.9% |
| 2021 | 0.44x | NT$159.51 Million | NT$360.10 Million | NT$152.26 Million | ▼ -15.8% |
| 2020 | 0.53x | NT$377.64 Million | NT$717.74 Million | NT$364.00 Million | ▲ +141.7% |
| 2019 | 0.22x | NT$109.40 Million | NT$502.62 Million | NT$104.17 Million | ▼ -93.6% |
| 2018 | 3.39x | NT$115.10 Million | NT$33.91 Million | NT$102.27 Million | ▼ -2.7% |
| 2017 | 3.49x | NT$218.92 Million | NT$62.76 Million | NT$177.91 Million | — |